Martin Treder

Martin Treder

Fundador en
LTZ Therapeutics, Inc.
.
Health Technology
Consumer Services
Commercial Services

Perfil

Martin Treder was the founder of U3 Pharma AG, founded in 2001, serving as Research Director in 2002.
Dr. Treder was the founder of CT Atlantic Ltd., founded in 2008, serving as Chief Scientific Officer from 2008 to 2014.
Dr. Treder is the founder of LTZ Therapeutics, Inc., founded in 2021, serving as Chief Scientific Officer since 2021.
Dr. Treder is the founder of Shenzhen LTZ Therapeutics Co., Ltd., founded in 2022.
Dr. Treder was Chief Scientific Officer at Affimed NV from 2015 to 2019.
Dr. Treder completed undergraduate studies at Monash University and earned a doctorate from Technische Universität München.

Cargos activos de Martin Treder

EmpresasCargoInicio
Fundador 01/01/2021

Antiguos cargos conocidos de Martin Treder.

EmpresasCargoFin
AFFIMED N.V. Director Técnico/Científico/I+D 22/05/2019
Fundador 01/12/2014
Fundador 01/10/2008
Fundador -
Ver el detalle de la experiencia de Martin Treder.

Formación de Martin Treder.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

13

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology